about
sameAs
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study GroupStructural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domainsCorrection: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesDesign of wide-spectrum inhibitors targeting coronavirus main proteasesMesoniviridae: a proposed new family in the order Nidovirales formed by a single species of mosquito-borne virusesStructure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain.Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugsCharacterization of Bafinivirus main protease autoprocessing activities.Improved dual promotor-driven reverse genetics system for influenza viruses.In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A VirusesThe PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.Mechanisms and enzymes involved in SARS coronavirus genome expression.Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA.Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes.The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells.Identification and characterization of a Golgi retention signal in feline coronavirus accessory protein 7b.Coronavirus cis-Acting RNA Elements.The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing.Proteolytic processing of mesonivirus replicase polyproteins by the viral 3C-like protease.Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology.Characterization of the 3rd International Standard for hepatitis B virus surface antigen (HBsAg).Studies of nosocomial outbreaks of hepatitis B in nursing homes in Germany suggest a major role of hepatitis B e antigen expression in disease severity and progression.Characterization of an alphamesonivirus 3C-like protease defines a special group of nidovirus main proteases.Development and evaluation of reverse transcription loop-mediated isothermal amplification assay for the detection of the fathead minnow nidovirus.Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.Structural and functional conservation of cis-acting RNA elements in coronavirus 5'-terminal genome regions.Inhibition of cytosolic phospholipase A2α impairs an early step of coronavirus replication in cell culture.Antiviral activity of K22 against members of the order Nidovirales.A Single-Center Study of Viral Respiratory Tract Infections in Hospitalized Children From the Kurdistan Region of IraqReverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious PeritonitisCharacterization of a bafinivirus exoribonuclease activityIdentification and Characterization of a Human Coronavirus 229E Nonstructural Protein 8-Associated RNA 3'-Terminal Adenylyltransferase ActivityDirect RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysisThe species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Structural basis for catalysis and substrate specificity of a 3C-like cysteine protease from a mosquito mesonivirusComparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor SilvestrolTranscription attenuation-derived small RNA rnTrpL regulates tryptophan biosynthesis gene expression in trans
P50
Q24604486-430C87D4-206D-4B7B-AF14-5EB344A0FBD8Q24674071-41CB82D1-679C-4C99-B86D-2460DCBC2820Q24817006-3722AE01-01F8-4823-9565-09E659897256Q24817106-F2B5E707-E8DC-4AD8-92A5-B050DFCF6D71Q26782053-192E93EE-F644-43F2-9867-0FC9A530E8E4Q27639290-945D5A9D-80F7-40B0-A4B6-D4D4A9F1361DQ27641252-95CE17DC-7676-4824-BF11-832D89A66A49Q30155962-5B35EA2F-6D5D-4AAE-A22D-C3427E1FD111Q30352337-A8138F6A-D873-42CF-B82D-293310109F2AQ30375878-43879318-8980-445D-8DB4-79F39B5217D9Q30383298-648CA840-2429-4D6D-B2A1-44E5D4FE43F7Q31153826-3C286481-A0DB-470D-9520-A0BA99973ECBQ35008803-95FB6FD3-41C8-47E3-968C-C6EC22FBA398Q35641245-0FB62869-5E1C-4892-BAE5-5376B3ED061EQ36326841-4ABE5CAE-9E7D-47EF-90E1-46BD007E3B00Q38652217-5B1F76DF-0238-4DC9-A616-5443A01F59E4Q38973824-3C811221-E268-4DBD-ACBF-AB53233A0C04Q38973838-254788D3-0871-4D9F-A782-9CA5E1234412Q39919935-0C5CFE8F-7DA8-4146-B40B-C5498FE1CA19Q40399208-4B06E4DA-147B-44EB-986D-B64BC090A9D0Q40636457-A5F92CB4-934F-4630-907F-AF39195C67F9Q41016570-48220BAC-13AA-4772-ABDC-1C9B693AFBFDQ41735298-A3E33B77-0B56-4A2F-ACAF-FAB102AE492AQ42233799-D831941B-8CC2-45B5-8F17-48A252DDA246Q47273832-58E80F5D-6DA1-4245-A8AD-ECB94CCC7FCEQ47337865-26405437-B2AF-44C3-B929-0F81EC3D78C1Q47372476-407ED4E2-F842-4E78-AFA2-93079F7359E1Q47553254-A74D90D3-3006-4A52-9B53-4FB2B83B07CEQ57003652-BDB050B2-DB5A-4C0C-9184-E0F412B44BBDQ59355602-9AB30470-F454-4C27-A11F-0A15161975EFQ59355731-86439A91-8D3B-469D-AA2A-7799FBE743F1Q84315404-885F07EC-7424-48B8-B087-6D0920214554Q84315550-E6FC3C26-6C2F-4FBD-A3A2-F28ACAC9B2A5Q87000965-f7dbba49-4e10-f557-5576-72e1e7c6c7deQ91950800-AC572182-DED8-47B3-88F7-BB7E1A1E4EC3Q92600834-F439F7DC-F32F-4C5D-878C-216F192F0984Q93143179-5715EE4C-E34B-4D7C-BA7C-6793BA37C0ED
P50
description
researcher
@en
wetenschapper
@nl
name
John Ziebuhr
@ast
John Ziebuhr
@en
John Ziebuhr
@es
John Ziebuhr
@nl
John Ziebuhr
@sl
type
label
John Ziebuhr
@ast
John Ziebuhr
@en
John Ziebuhr
@es
John Ziebuhr
@nl
John Ziebuhr
@sl
prefLabel
John Ziebuhr
@ast
John Ziebuhr
@en
John Ziebuhr
@es
John Ziebuhr
@nl
John Ziebuhr
@sl
P106
P21
P31
P496
0000-0002-5741-8825